Skip to main content
. 2014 Nov 14;9(11):e112583. doi: 10.1371/journal.pone.0112583

Table 4. Effect of vWF levels on primary hemostasis in thrombocytopenic patients with cirrhosis.

25 µg r-vWF 66 µg anti-vWF 156 µg anti-vWF
Col-Epi
Col-ADP

Overview of the main results: changes in closure times after addition of either recombinant vWF or anti-vWF-antibody (↔: no change, ↓: improved, ↑: worsened).